CLONIDINE HYDROCHLORIDE- clonidine hydrochloride tablet

Land: Vereinigte Staaten

Sprache: Englisch

Quelle: NLM (National Library of Medicine)

Wirkstoff:

CLONIDINE HYDROCHLORIDE (UNII: W76I6XXF06) (CLONIDINE - UNII:MN3L5RMN02)

Verfügbar ab:

NCS HealthCare of KY, Inc dba Vangard Labs

Verabreichungsweg:

ORAL

Verschreibungstyp:

PRESCRIPTION DRUG

Anwendungsgebiete:

Clonidine hydrochloride tablets are indicated in the treatment of hypertension. Clonidine hydrochloride tablets may be employed alone or concomitantly with other antihypertensive agents. Clonidine hydrochloride tablets should not be used in patients with known hypersensitivity to clonidine (see PRECAUTIONS ).

Produktbesonderheiten:

Clonidine Hydrochloride Tablets USP are supplied as: 0.1 mg White rounded off oval shaped, biconvex tablets, with score line having "U" and "135" debossed across the score line on one side and plain on other side. Blistercards of 30: NDC 0615-7947-39 0.2 mg White rounded off oval shaped, biconvex tablets, with score line having "U" and "136" debossed across the score line on one side and plain on other side. Blistercards of 30: NDC 0615-7948-39 Unit-dose Boxes of 30: NDC 0615-7948-30 0.3 mg White rounded off oval shaped, biconvex tablets with score line having "U" and "137" debossed across the score line on one side and plain on other side. Blistercards of 30: NDC 0615-8164-39 Store at 20º- 25ºC (68º- 77ºF) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container. Please address medical inquires to Unichem's toll free # 1-866-562-4616. Manufactured by: UNICHEM LABORATORIES LTD. Pilerne Ind. Estate, Pilerne, Bardez, Goa 403 511, India Manufactured for: Hasbrouch Heights, NJ 07604. 05-R-10/2017 13009854

Berechtigungsstatus:

Abbreviated New Drug Application

Fachinformation

CLONIDINE HYDROCHLORIDE- CLONIDINE HYDROCHLORIDE TABLET
NCS HEALTHCARE OF KY, INC DBA VANGARD LABS
----------
CLONIDINE HYDROCHLORIDE TABLETS, USP 0.1 MG, 0.2 MG, 0.3 MG
RX ONLY
DESCRIPTION
Clonidine hydrochloride, USP is a centrally acting alpha-agonist
hypotensive agent available as tablets
for oral administration in three dosage strengths: 0.1 mg, 0.2 mg and
0.3 mg. The 0.1 mg tablet is
equivalent to 0.087 mg of the free base.
The inactive ingredients are colloidal silicon dioxide, corn starch,
dibasic calcium phosphate, sodium
starch glycolate, glycerin, lactose monohydrate, magnesium stearate,
povidone.
Clonidine hydrochloride is an imidazoline derivative and exists as a
mesomeric compound. The
chemical name is 2-(2,6-dichlorophenylamino)-2-imidazoline
hydrochloride. The following is the
structural formula:
Clonidine hydrochloride is an odorless, bitter, white, crystalline
substance soluble in water and
alcohol.
CLINICAL PHARMACOLOGY
Clonidine stimulates alpha-adrenoreceptors in the brain stem. This
action results in reduced sympathetic
outflow from the central nervous system and in decreases in peripheral
resistance, renal vascular
resistance, heart rate, and blood pressure. Clonidine hydrochloride
tablets acts relatively rapidly. The
patient's blood pressure declines within 30 to 60 minutes after an
oral dose, the maximum decrease
occurring within 2 to 4 hours. Renal blood flow and glomerular
filtration rate remain essentially
unchanged. Normal postural reflexes are intact; therefore, orthostatic
symptoms are mild and infrequent.
Acute studies with clonidine hydrochloride in humans have demonstrated
a moderate reduction (15% to
20%) of cardiac output in the supine position with no change in the
peripheral resistance: at a 45º tilt
there is a smaller reduction in cardiac output and a decrease of
peripheral resistance. During long term
therapy, cardiac output tends to return to control values, while
peripheral resistance remains decreased.
Slowing of the pulse rate has been observed in most patients given
c